News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Ruben Mesa: Excited to be a co-investigator of the MANIFEST2 trial presented by Alessandro Vannucchi at EHA25
Wake Forest University School of Medicine/LinkedIn
Jun 14, 2025, 06:53

Ruben Mesa: Excited to be a co-investigator of the MANIFEST2 trial presented by Alessandro Vannucchi at EHA25

Ruben Mesa, President and Executive Director of Atrium Health Levine Cancer Institute and Atrium Health Wake Forest Baptist Comprehensive Cancer Center, shared a post on LinkedIn:

“Excited to be a co-investigator of the MANIFEST2 trial presented by Alessandro Vannucchi at EHA25. The 72-week data of the combination of Pelabresib plus Ruxolitinib showed durably superior responses for the combination for control of splenomegaly and dual responders.”

Ruben Mesa: Excited to be a co-investigator of the MANIFEST2 trial presented by Alessandro Vannucchi at EHA25

More posts featuring Ruben Mesa.

Alessandro Vannucchi cancer EHA25 MANIFEST2 trial OncoDaily Oncology Pelabresib Ruben Mesa ruxolitinib
Special Coverage
Dialogues
Aug 15, 2025, 08:28
ONCOFFEE: Vera Megdanova on Oncology, Family, and the Challenges of Practicing Medicine in Bulgaria
Blog Posts
Aug 15, 2025, 08:03
Carmen Monge-Montero: Sometimes the Bravest Thing You Can Do is Ask for Help
Science
Aug 15, 2025, 07:31
Bishoy Morris Faltas: Paired Plus-Minus Sequencing for Accurate Dual-Strand DNA Analysis
Stories
Aug 15, 2025, 06:47
Oya Gilbert's Story Highlights Urgent Need to Protect NIH Research Funding - AACR
Science
Aug 15, 2025, 06:42
Denis Panizza: How Tight Can SBRT Prostate Margins Go?
Science
Aug 15, 2025, 06:33
Immune Youth in Old Age: Mayo Clinic Uncovers the Double-Edged Sword - E. Shyam P. Reddy
Voices
Aug 15, 2025, 06:32
Where AI Meets the Future of Cancer Research - NFCR
Insight
Aug 15, 2025, 06:24
Harpreet Singh: New Era for ADCs in HER-2 + Metastatic Breast Cancer
Science
Aug 15, 2025, 06:18
Ramy Sedhom Shares Study on Inpatient Immunotherapy Outcomes
Science
Aug 15, 2025, 06:11
Miguel Bronchud: Can Use of Aprepitant During Chemotherapy Improve TNBC Outcomes?
Voices
Aug 15, 2025, 06:04
Lung Cancer in Africa: Gaps and Role of a Community of Practice - Move Against Cancer Africa
Voices
Aug 15, 2025, 05:56
Megan Burger: Huge Day for Cancer Care